NEW YORK (GenomeWeb) – IntegraGen and GoPath Laboratories said today that they have signed a non-exclusive licensing agreement under which GoPath plans to commercialize a test based on IntegraGen's proprietary miR-31-3p biomarker in the US and Canada.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.